Aclaris Therapeutics ACRS Return on invested capital

Return on invested capital at other companies

IncyteINCY

62.6%+24.7pp

Corvus PharmaceuticalsCRVS

-38.8%-13.8pp

Upstream Bio, Inc.UPB

-61%—

Avalo TherapeuticsAVTX

-42.9%—

Shattuck Labs, Inc.STTK

-69.7%-27.7pp

Cullinan Therapeutics, Inc.CGEM

-58%+22.6pp

FAQ

What is Aclaris Therapeutics's return on invested capital?

Aclaris Therapeutics (ACRS) reported return on invested capital of -79.9% in Q2 2026.

How has Aclaris Therapeutics's return on invested capital changed year-over-year?

Aclaris Therapeutics's return on invested capital increased by 39.4% year-over-year, from -131.8% to -79.9%.

What is the long-term trend for Aclaris Therapeutics's return on invested capital?

Over 5 years (2020 to 2025), Aclaris Therapeutics's return on invested capital has grown at a -14.2% compound annual growth rate (CAGR), from -150% to -69.8%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.